{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:13:49Z","timestamp":1784117629774,"version":"3.55.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Subsets of patients diagnosed with a monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM) or multiple myeloma (MM), present with a monoclonal immunoglobulin (Ig) specific for an infectious pathogen, including hepatitis C and B viruses (HCV, HBV), <jats:italic>Helicobacter pylori<\/jats:italic> and several <jats:italic>Herpesviruses<\/jats:italic>. Such cases are likely initiated by infection, since in the context of HCV- or HBV-infected patients, antiviral therapy can lead to the disappearance of antigenic stimulation, control of clonal plasma cells, and reduced or suppressed monoclonal Ig production. Complete remission has been obtained with anti-HCV therapy in refractory MM with a HCV-specific monoclonal Ig, and antiviral treatments significantly improved the probability of survival of MM patients infected with HCV or HBV prior to the diagnosis of MM. Monoclonal Igs may also target glucolipids, particularly glucosylsphingosine (GlcSph), and GlcSph-reducing therapy can lead to complete remission in SMM and MM patients presenting with a GlcSph-specific monoclonal Ig. The present review describes the importance of determining the target of the monoclonal Ig of MGUS, SMM and MM patients, and discusses the efficacy of target-reducing treatments in the management of MGUS, SMM and MM cases who present with a monoclonal Ig reactive against a treatable infectious pathogen or GlcSph.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1253363","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T11:40:40Z","timestamp":1698752440000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Determination of the target of monoclonal immunoglobulins: a novel diagnostic tool for individualized MGUS therapy, and prevention and therapy of smoldering and multiple myeloma"],"prefix":"10.3389","volume":"14","author":[{"given":"Sylvie","family":"Hermouet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Bigot-Corbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Harb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281802","article-title":"Monoclonal gammopathy of increasing significance: time to screen","volume":"108","author":"Chen","year":"2022","journal-title":"Haematologica"},{"key":"B3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1182\/asheducation-2017.1.194","article-title":"Shall we treat smoldering multiple myeloma in the near future","volume":"2017","author":"Landgren","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009658.","article-title":"Is aggressive treatment of smoldering myeloma the path to curing myeloma","volume":"7","author":"Chakraborty","year":"2023","journal-title":"Blood Adv"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer Oxf Engl"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-04220-6_11","article-title":"Infections in patients with leukemia and lymphoma","volume":"161","author":"Morrison","year":"2014","journal-title":"Cancer Treat Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2135-z","article-title":"Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies","volume":"73","author":"Guillerey","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9151-8_1","article-title":"Origin and pathogenesis of B cell lymphomas","volume":"1956","author":"Seifert","year":"2019","journal-title":"Methods Mol Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1084\/jem.20121801","article-title":"A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi","volume":"210","author":"Hoogeboom","year":"2013","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.149252","article-title":"Trained immunity: consequences for lymphoid Malignancies","volume":"101","author":"Stevens","year":"2016","journal-title":"Haematologica"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28479","article-title":"Common community-acquired infections and subsequent risk of multiple myeloma: A population-based study: Infections and multiple myeloma","volume":"134","author":"McShane","year":"2014","journal-title":"Int J Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12742","article-title":"Hepatitis C virus infection and risk of multiple myeloma: Evidence from a meta-analysis based on 17 case-control studies","volume":"24","author":"Li","year":"2017","journal-title":"J Viral Hepat"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.anndiagpath.2016.09.002","article-title":"Solitary plasmacytoma associated with Epstein-Barr virus: a clinicopathologic, cytogenetic study and literature review","volume":"27","author":"Yan","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200301093480219","article-title":"Hepatitis C virus, human herpesvirus 8, and the development of plasma-cell leukemia","volume":"348","author":"Hermouet","year":"2003","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402748","article-title":"Qualitative and quantitative analysis of human herpesvirus expression in chronic and acute B-cell lymphocytic leukemia and in multiple myeloma","volume":"17","author":"Hermouet","year":"2003","journal-title":"Leukemia"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-167569","article-title":"Hepatitis C virus (HCV) infection, monoclonal immunoglobulin specific for HCV core protein, and plasma-cell Malignancy","volume":"112","author":"Bigot-Corbel","year":"2008","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e95367","DOI":"10.1172\/jci.insight.95367","article-title":"Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens","volume":"2","author":"Bosseboeuf","year":"2017","journal-title":"JCI Insight"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00854","article-title":"Analysis of the targets and glycosylation of monoclonal igAs from MGUS and myeloma patients","volume":"11","author":"Bosseboeuf","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e98259","DOI":"10.1172\/jci.insight.98259","article-title":"Antigen-mediated regulation in monoclonal gammopathies and myeloma","volume":"3","author":"Nair","year":"2018","journal-title":"JCI Insight"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal immunoglobulin against lysolipids in the origin of myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2020.01.009","article-title":"Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy","volume":"129","author":"Nair","year":"2020","journal-title":"Mol Genet Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.797209","article-title":"Efficacy of antiviral treatment in Hepatitis C virus (HCV)-driven monoclonal gammopathies including myeloma","volume":"12","author":"Rodriguez-Garcia","year":"2022","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283096","article-title":"Impact of Viral Hepatitis Therapy in Multiple Myeloma and other Monoclonal Gammopathies linked to Hepatitis B or C Viruses","volume":"109","author":"Rodr\u00edguez-Garc\u00eda","year":"2024","journal-title":"Haematologica"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283461","article-title":"Exploring the role of viral hepatitis in plasma cell disorders","volume":"109","author":"O'Donnell","year":"2024","journal-title":"Haematologica"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051254","article-title":"Characteristics of MGUS and multiple myeloma according to the target of monoclonal immunoglobulins, glucosylsphingosine, or epstein-barr virus EBNA-1","volume":"12","author":"Bosseboeuf","year":"2020","journal-title":"Cancers"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.123828","article-title":"Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa\/lambda ratios","volume":"55","author":"Bradwell","year":"2009","journal-title":"Clin Chem"},{"key":"B27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41408-019-0263-z","article-title":"Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement","volume":"9","author":"Murray","year":"2019","journal-title":"Blood Cancer J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00069-2","article-title":"Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study","volume":"9","author":"El-Khoury","year":"2022","journal-title":"Lancet Haematol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18226","article-title":"Pratt G. The potential role of mass spectrometry for the identification and monitoring of patients with plasma cell disorders: Where are we now and which questions remain unanswered","volume":"198","author":"Giles","year":"2022","journal-title":"Br J Haematol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013794","article-title":"Redefining non measurable multiple myeloma using mass spectrometry","volume":"139","author":"Giles","year":"2022","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00772-9","article-title":"Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma","volume":"13","author":"Mai","year":"2023","journal-title":"Blood Cancer J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01347","article-title":"Pro-inflammatory state in MGUS and Myeloma is characterized by low sialylation of pathogen-specific and other monoclonal and polyclonal immunoglobulin G","volume":"8","author":"Bosseboeuf","year":"2017","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2012.10.012","article-title":"Multiplexed infectious protein microarray immunoassay suitable for the study of the specificity of monoclonal immunoglobulins","volume":"433","author":"Feron","year":"2013","journal-title":"Anal Biochem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.960829","article-title":"The role of microorganisms in multiple myeloma","volume":"13","author":"Linares","year":"2022","journal-title":"Editorial. Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020438","article-title":"Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs other Infectious Pathogens","volume":"10","author":"Harb","year":"2021","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.876271","article-title":"Autoimmunity, infections, and the risk of Monoclonal Gammopathy of Undetermined Significance","volume":"13","author":"Sigurbergsd\u00f3ttir","year":"2022","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15659","article-title":"Saposin C is a frequent target of paraproteins in Gaucher disease-associated MGUS\/multiple myeloma","volume":"184","author":"Preuss","year":"2019","journal-title":"Br J Haematol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.4.1225","article-title":"IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside","volume":"81","author":"Ilyas","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/0009-3084(86)90055-1","article-title":"Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system","volume":"42","author":"Quarles","year":"1986","journal-title":"Chem Phys Lipids"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb01206.x","article-title":"The epitope(s) recognized by HNK-1 antibody and IgM paraprotein in neuropathy is present on several N-linked oligosaccharide structures on human P0 and myelin-associated glycoprotein","volume":"54","author":"Burger","year":"1990","journal-title":"J Neurochem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(97)00209-9","article-title":"Antibodies to chondroitin sulfate C: a new detection assay and correlations with neurological diseases","volume":"84","author":"Briani","year":"1998","journal-title":"J Neuroimmunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(00)00342-7","article-title":"Anti-sulfatide IgM antibodies in peripheral neuropathy","volume":"176","author":"Carpo","year":"2000","journal-title":"J Neurol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13387","article-title":"Anti-sulfatide\/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies","volume":"24","author":"Boso","year":"2017","journal-title":"Eur J Neurol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7612-4","article-title":"Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case-control study","volume":"262","author":"Vlam","year":"2015","journal-title":"J Neurol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"Fermand","year":"2018","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280953","article-title":"IgM monoclonal gammopathies of clinical significance: diagnosis and management","volume":"107","author":"Khwaja","year":"2022","journal-title":"Haematologica"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199907000-00003","article-title":"Subepidermal auto-immune bullous skin diseases associated with B-cell lymphoproliferative disorders","volume":"78","author":"Aractingi","year":"1999","journal-title":"Med (Baltimore)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1053\/j.ajkd.2004.09.029","article-title":"Recurrent Good-pasture\u2019s disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1\/alpha2 chains of type IV collagen","volume":"45","author":"Borza","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03643.x","article-title":"Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy","volume":"11","author":"Debiec","year":"2011","journal-title":"Am J Transplant"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13563","article-title":"Autoimmune disease is associated with a lower risk of progression in Monoclonal Gammopathy of Undetermined Significance","volume":"106","author":"Baldursd\u00f3ttir","year":"2021","journal-title":"Eur J Haematol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11940-017-0479-9","article-title":"Advances in the treatment of paraproteinemic neuropathy","volume":"19","author":"Nobile-Orazio","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/hemato3040045","article-title":"Polyneuropathy associated with IgM monoclonal gammopathy: Advances in genetics and treatment, focusing on anti-MAG antibodies","volume":"3","author":"van de Mortel","year":"2022","journal-title":"Hemato"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190284","article-title":"Epstein-Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma","volume":"39","author":"Xia","year":"2019","journal-title":"Biosci Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/path.4452","article-title":"Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell Malignancy","volume":"235","author":"Pavlova","year":"2015","journal-title":"J Pathol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.lrr.2013.01.002","article-title":"Regression of a case of multiple myeloma with antiviral treatment in a patient with chronic HCV infection","volume":"2","author":"Panfilio","year":"2013","journal-title":"Leuk Res Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00277-021-04746-y","article-title":"Management of herpesvirus reactivations in patients with solid tumours and hematologic Malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus","volume":"101","author":"Henze","year":"2022","journal-title":"Ann Hematol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12624","article-title":"Importance of compliance with guidelines for the prevention of varicella-zoster virus reactivation in multiple myeloma","volume":"35","author":"Ohashi","year":"2021","journal-title":"In Vivo"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05668.x","article-title":"Role of Helicobacter pylori infection in the incidence and clinical course of monoclonal gammopathy of undetermined significance","volume":"97","author":"Malik","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0684-4","article-title":"pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort study","volume":"88","author":"Soler","year":"2009","journal-title":"Ann Hematol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.925266","article-title":"The Yin\u2013Yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma","volume":"13","author":"Yi","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1253363\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T11:40:42Z","timestamp":1698752442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1253363\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2023.1253363"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1253363","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"article-number":"1253363"}}